Canada's Organigram shops for U.S. pot businesses with backing from British American Tobacco
Portfolio Pulse from
Organigram, a Canadian legal cannabis company, is seeking to acquire U.S. cannabis businesses with financial support from British American Tobacco. The company has reported revenue growth and a reduction in losses, aligning with its acquisition strategy.
December 18, 2024 | 2:00 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
British American Tobacco is financially backing Organigram's acquisition of U.S. cannabis businesses. This move could diversify BTI's portfolio and potentially increase its revenue streams.
British American Tobacco's support for Organigram's acquisitions in the U.S. cannabis market could lead to diversification and new revenue opportunities, positively impacting BTI's stock.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 80